rs11026318 - ANO5

Magnitude 4.5 · 1 study on file

Reported associations

• The CCND1 870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma - Unknown journal (n.d.) · Unknown authors · PubMed 23502783

  ABSTRACT: A number of specific chromosomal abnormalities define the subgroups of multiple myeloma. In a meta-analysis of two genomewide association studies of multiple myeloma totaling 1,661 patients we investigated risk for developing a specific tumor karyotype. The t(11;14) (q13;q32) translocation in which CCDN1 is placed under the control of the immunoglobin heavy chain enhancer was strongly associated with the CCDN1 870G>A polymorphism (P =7.96 x10-11). These results provide for a model in which a constitutional genetic factor is associated with risk of a specific chromosomal translocation. FULL TEXT: [INTRO] Multiple myeloma is a malignancy of the plasma cells that primarily localize to the bone marrow. Multiple myeloma can be broadly divided into hyperdiploid (HD) and non-hyperdiplo

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.